| P50 | author | Pascal Jézéquel | Q40378776 |
| P2093 | author name string | Philippe Juin | |
| | Sophie Barillé-Nion | |
| | Eloïse Véquaud | |
| | Grégoire Desplanques | |
| P2860 | cites work | Histone H3 Thr-3 phosphorylation by Haspin positions Aurora B at centromeres in mitosis | Q24295107 |
| | Bcl-2 inhibits nuclear homologous recombination by localizing BRCA1 to the endomembranes | Q24298246 |
| | Survivin is required for a sustained spindle checkpoint arrest in response to lack of tension | Q24305061 |
| | Premature activation of the SLX4 complex by Vpr promotes G2/M arrest and escape from innate immune sensing | Q24318920 |
| | Direct interaction between survivin and Smac/DIABLO is essential for the anti-apoptotic activity of survivin during taxol-induced apoptosis | Q28186614 |
| | A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer | Q28297827 |
| | A novel small molecule FL118 that selectively inhibits survivin, Mcl-1, XIAP and cIAP2 in a p53-independent manner, shows superior antitumor activity | Q28483886 |
| | GammaH2AX and cancer | Q29614974 |
| | Hallmarks of 'BRCAness' in sporadic cancers | Q29618825 |
| | Chromosomal passengers: conducting cell division | Q29620468 |
| | A genome-wide siRNA screen reveals diverse cellular processes and pathways that mediate genome stability | Q33489221 |
| | Survivin family proteins as novel molecular determinants of doxorubicin resistance in organotypic human breast tumors. | Q33827053 |
| | Survivin, cancer networks and pathway-directed drug discovery. | Q55046676 |
| | Survivin inhibition and DNA double-strand break repair: a molecular mechanism to overcome radioresistance in glioblastoma. | Q55462901 |
| | Radiosensitizing effect of YM155, a novel small-molecule survivin suppressant, in non-small cell lung cancer cell lines | Q64387501 |
| | Spontaneous and radiation-induced apoptosis in colorectal carcinoma cells with different intrinsic radiosensitivities: survivin as a radioresistance factor | Q73166839 |
| | BIR-1, a Caenorhabditis elegans homologue of Survivin, regulates transcription and development | Q34982547 |
| | Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response | Q35314135 |
| | YM155 potently triggers cell death in breast cancer cells through an autophagy-NF-kB network | Q35955360 |
| | Compartmentalized phosphorylation of IAP by protein kinase A regulates cytoprotection | Q36002989 |
| | Homologous recombination and its regulation | Q36106937 |
| | Bcl-xL controls a switch between cell death modes during mitotic arrest | Q36179601 |
| | bc-GenExMiner 3.0: new mining module computes breast cancer gene expression correlation analyses | Q36543286 |
| | Interplay among BRCA1, SIRT1, and Survivin during BRCA1-associated tumorigenesis | Q36958613 |
| | Molecular dependence of estrogen receptor-negative breast cancer on a notch-survivin signaling axis | Q37120385 |
| | Mitotic deregulation by survivin in ErbB2-overexpressing breast cancer cells contributes to Taxol resistance | Q37146751 |
| | New wirings in the survivin networks | Q37302750 |
| | Structure-specific endonucleases: guardians of fragile site stability | Q38173146 |
| | Survivin and YM155: how faithful is the liaison? | Q38179783 |
| | miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer | Q38883702 |
| | ERCC1 and MUS81-EME1 promote sister chromatid separation by processing late replication intermediates at common fragile sites during mitosis | Q39133182 |
| | Transcriptional inhibition of p21WAF1/CIP1 gene (CDKN1) expression by survivin is at least partially p53-dependent: evidence for survivin acting as a transcription factor or co-factor | Q39364694 |
| | DNA damage foci in mitosis are devoid of 53BP1. | Q39791011 |
| | Survivin may enhance DNA double-strand break repair capability by up-regulating Ku70 in human KB cells | Q39866707 |
| | Altered cytoplasmic-to-nuclear ratio of survivin is a prognostic indicator in breast cancer | Q39986329 |
| | Mechanisms of cell sensitization to alpha radioimmunotherapy by doxorubicin or paclitaxel in multiple myeloma cell lines | Q40365987 |
| | Survivin enhances radiation resistance in primary human glioblastoma cells via caspase-independent mechanisms | Q40522890 |
| | Survivin as a therapeutic target for radiation sensitization in lung cancer. | Q40566190 |
| | Prognostic significance of survivin in breast cancer: meta-analysis | Q43464457 |
| | bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer | Q45794158 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 53-63 | |
| P577 | publication date | 2015-12-18 | |
| P1433 | published in | Breast Cancer Research and Treatment | Q326085 |
| P1476 | title | Survivin contributes to DNA repair by homologous recombination in breast cancer cells | |
| P478 | volume | 155 | |